Instructions for Credit — This activity is accredited for 1.5 continuing education credit for nurse practitioners, nurses and social workers. Participants must attend the free webinar in its entirety, submit the online evaluation form and complete and submit the online post-test with a passing score of 70% to earn credit. Once submitted, the certificate will be automatically generated as a PDF online.
Please retain a copy of the certificate for your records. For questions regarding the accreditation of this activity, please contact Medical Learning Institute, Inc. at (609) 333-1693 or email@example.com.
You must be enrolled to complete this activity for credit, however, you are not required to enroll simply to view the presentation.
Target Audience — Nurse practitioners, nurses, social workers and other healthcare providers involved in the care of patients with hematologic malignancies.
Course Content Level for Social Workers — all levels
Format — Non-interactive recorded webinar with videos
Description — It has been 60 years since the discovery of a chromosomal abnormality in CML; the so-called Philadelphia chromosome. Since then genomics has revolutionized cancer care and the impact in hematologic malignancies is plentiful. Healthcare providers must understand the science to be able to apply in practice and communicate complex information to patients and caregivers. This session will provide an overview of foundational genomic concepts and how genomics is applied across the care continuum for hematologic cancers. Case studies examining the application of testing to “real life” situations will be presented and resources for patients will be shared.
|Learning Objectives — At the conclusion of this program, participants will be able to:|
|•||Discuss foundational genomic concepts (DNA, gene, chromosome, somatic and germline genomic variants)|
|•||Discuss and define biomarkers and biomarker testing|
|•||Identify appropriate biomarker (genomic) testing for hematologic cancers across the care continuum (diagnosis, prognosis, treatment, disease monitoring)|
|•||Describe the role of the nurse, APRN, and others on the healthcare team in preparing patients and caregivers for biomarker testing, including access and financial implications|
|•||Identify resources to educate and support patients and caregivers regarding biomarker testing|
Provider — This activity is provided by The Leukemia & Lymphoma Society.
Registered Nursing Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.5 continuing education contact hours through the California Board of Registered Nursing.
Social Worker Designation
The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. LLS maintains responsibility for this course. ACE provider approval period: 12/10/2020-12/10/2023. Social workers completing this course receive 1.5 continuing education credit.
The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0117. LLS maintains responsibility for this program. Social workers will receive 1.5 CE clinical contact hour for this activity.
To view system requirements please go to https://llsce.org/system-requirements
For questions, grievances, or assistance with special needs (physical, etc.) please contact us at ProfEducation@LLS.org.
Disclosure of Conflicts of Interest — All faculty participating in continuing education activities by The Leukemia & Lymphoma Society are expected to disclose to activity participants any significant financial interest or other relationships with the manufacturer(s) of any commercial product(s) discussed in their presentations. The faculty are also expected to disclose any unlabeled or investigational uses of any product(s) discussed in their presentations.
Patricia Friend, PhD, APRN-CNS, AOCNS, AGN-BC, has no financial disclosures.
Eric Zack, DNP, RN, ACNP-BC, AOCN, BMTCN, has a financial interest/relationship or affiliation: honoraria/consulting fee for Careview, a testicular cancer patient app.
Disclaimer — Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
|Estimated time to complete activity: 1.5 hours|
|Date of initial release: June 24, 2021|
|Expiration date: December 30, 2022|
Patricia Friend, PhD, APRN-CNS, AOCNS, AGN-BC, has advanced certification in oncology nursing, is board certified in advanced genetics nursing, and is licensed as an APRN-CNS (Clinical Nurse Specialist). Her areas of expertise are in oncology and genomics, educational preparation of advanced practice nurses, online education, and interprofessional education and practice. Her doctoral dissertation work was supported by the American Cancer Society (doctoral scholarship), and a predoctoral fellowship (F31) from the National Cancer Institute. Her doctoral research was funded by the National Cancer Institute, the Oncology Nursing Foundation, and the Chicago Chapter of the Oncology Nursing Society. In addition, she has experience with educational training grants.
Genetics/genomics are Dr. Friend’s main areas of clinical scholarship and research interest. The implications of genomic discoveries for individuals and families will continue to expand rapidly. Health care providers and scientists/practitioners in all relevant fields will need to become proficient and expert not only in the scientific knowledge base in order to translate and apply genomic discoveries to improve health, but also in the skill of communicating and discussing genetic/genomic results as well as the impact of such results on families and familial relationships. She serves on the Genomics Advisory Board for the Oncology Nursing Society and on the Association of Community Cancer Centers Advisory Committee for cancer biomarker testing. She is interested in improving genomic literacy of health care educators, students, and clinicians. She has taught a cancer genomics course for graduate nursing students for many years and is developing an R25 grant for genomics education for oncology nurses.
Eric Zack, DNP, RN, ACNP-BC, AOCN, BMTCN, is a doctoral prepared advanced practice nurse who currently works as an assistant professor at Loyola University-Chicago and part-time as a RN3 (staff and charge nurse) on an inpatient hematology/HSCT unit. He has worked at Rush University Medical Center for 24 years and at Loyola Universtiy for almost 2 years. He has published several textbook chapters over the years in Cancer Nursing: Principles and Practice (Jones & Bartlett Learning) and multiple peer-reviewed articles in Oncology Nursing Forum, Clinical Journal of Oncology Nursing, MedSurg Nursing, and Journal of Infusion Nursing. He has presented several posters and podiums at several conferences, including ANCC (Magnet Recognition Program), Oncology Nursing Society, and the Infusion Nurses Society. He currently serves as Director-at-Large for Programs and Education for the Chicago Chapter of the Oncology Nursing Society, serves as co-secretary for a local chapter of Sigma Theta Tau (International), and contributes to ONCC’s Blood and Marrow Transplantation Certified Nurse Exam Test Development Committee.
Resources for HCPs
Free CME & CE courses: www.LLS.org/CE
Treating Blood Cancers podcasts: www.LLS.org/HCPpodcast
HCP Facts About Molecular Profiling: www.LLS.org/CE. Click on publications.
HCP Facts About CAR T-cell Therapy: www.LLS.org/CE. Click on publications.
Clinical Trials and Research
- Clinical Trials: Learn more about clinical trials: www.LLS.org/ClinicalTrials
- Research: Focused on finding cures, driving research in areas of unmet medical need, and bridging the gap between academic discovery & drug development: www.LLS.org/Research
Advocacy dedicated to removing barriers to care: www.LLS.org/Advocacy
Resources for Patients
Free Information Booklets on genetics, molecular profiling, blood cancers and support: www.LLS.org/Booklets
Telephone/Web Education Programs: www.LLS.org/Programs
Podcast series for patients and caregivers: www.LLS.org/podcast
Support Resources : www.LLS.org/Support
- Financial Assistance
- Travel Assistance
- Referral to Medication Access programs
- Information Resource Center
- LLS Chapters
- LLS Community (social media platform)
- Patti Robinson Kaufman First Connection Program (peer-to-peer)
- One-On-One Nutrition Consultations (PearlPoint)
Information Resource Specialists: www.LLS.org/IRC
Assist through treatment, financial & social challenges, and give accurate treatment and support information. HCPs can also order free materials to distribute to patients.
Clinical Trial Support Center: www.LLS.org/CTSC
Patients & caregivers work one-on-one with an LLS Clinical Trial Nurse Navigator who will help find clinical trials and personally assist throughout the clinical trial process, providing an additional resource to the HCP team
- Phone: (800) 955-4572, M-F, 9 am to 9 pm ET
- Email: infocenter@LLS.org
Live chat: www.LLS.org/InformationSpecialists
If you have any questions, please contact us at ProfEducation@LLS.org or call our Information Resource staff at 800-955-4572.